STOCK TITAN

Waters Corp - WAT STOCK NEWS

Welcome to our dedicated page for Waters news (Ticker: WAT), a resource for investors and traders seeking the latest updates and insights on Waters stock.

Waters Corporation (NYSE: WAT) is a global leader in the field of analytical instruments and software solutions. For nearly six decades, the company has pioneered advancements in chromatography, mass spectrometry, and thermal analysis, catering to life, materials, and food sciences. Headquartered in Milford, Massachusetts, Waters Corp. operates directly in 35 countries, supported by approximately 8,000 employees and 15 manufacturing facilities globally.

Waters' main business segments include Waters, TA Instruments, VICAM, ERA, and Nonlinear Dynamics. The company's diverse product portfolio features ultra-performance liquid chromatography (UPLC), high-performance liquid chromatography (HPLC), chromatography columns, mass spectrometry systems, and laboratory informatics solutions. These innovations empower laboratory-dependent organizations to achieve advancements in healthcare, environmental management, food safety, and water quality.

Waters Corporation serves a wide array of customers, including biopharmaceutical companies (57% of sales), industrial clients (31% of sales), and academic/government institutions (12% of sales). The company’s products are available in over 100 countries, ensuring a broad market reach.

Recent achievements include the launch of new accessories for TA Instruments Discovery Hybrid Rheometers, designed for battery formulation analysis, and the introduction of Oasis WAX/GCB and GCB/WAX Cartridges for PFAS analysis. These innovations reflect the company’s commitment to addressing emerging scientific challenges and regulatory requirements. Additionally, Waters continues to enhance its mass spectrometry capabilities with products like the ACQUITY QDa II Mass Detector and the Xevo MRT MS, aimed at accelerating research in pharmaceuticals, food, chemicals, and materials.

Financially, Waters Corporation reported first-quarter 2024 sales of $637 million, with a strategic focus on innovation and operational efficiency. Despite a 7% decrease in sales compared to the previous year, the company remains optimistic about future growth, driven by new product launches and higher growth areas.

Waters Corporation stands as a pivotal player in the analytical instruments industry, consistently driving scientific advancements and operational excellence.

Rhea-AI Summary

WAT Medical introduces ObeEnd, a revolutionary weight management wristband supported by clinical evidence. The device aims to address the global obesity epidemic by providing a drug-free, effective solution. ObeEnd utilizes neuromodulation technology to reduce caloric intake and enhance post-exercise recovery, showing promising results in clinical studies. The groundbreaking innovation marks a major milestone in the field of weight management.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.52%
Tags
none
-
Rhea-AI Summary

Waters announced the release of the ACQUITY QDa II Mass Detector, a cost-effective, energy-efficient instrument that enhances compound identification through mass analysis. The new detector offers a 20% increase in mass range, up to 70% lower energy consumption, and is recognized for sustainability by My Green Lab.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.69%
Tags
-
Rhea-AI Summary

Waters (NYSE: WAT) reported first-quarter 2024 financial results with sales of $637 million, a 7% decline, but at the high end of guidance. GAAP EPS was $1.72, well above guidance, with non-GAAP EPS of $2.21. Operational excellence led to gross margin expansion. Full-year guidance maintained for -0.5% to +1.5% organic constant currency sales growth and non-GAAP EPS of $11.75 to $12.05.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.94%
Tags
Rhea-AI Summary
Waters introduces new GTxResolve Premier SEC Columns to accelerate the development of gene-based therapeutics. The columns offer higher sensitivity, resolution, and throughput, reducing non-specific binding, minimizing method development challenges, and increasing separation efficiency. They provide up to 50% more resolution for components in mRNA, LNP, and viral vectors, aiding in measuring critical quality attributes. The SEC columns support the growing demand for nucleic acid therapeutics and streamline biological license applications and release testing strategies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.06%
Tags
none
-
Rhea-AI Summary
Waters (WAT) will host its Q1 2024 financial results conference call on May 7th, 2024, providing a live webcast for investors to access. The webcast replay will be available until June 4th, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.22%
Tags
-
Rhea-AI Summary
Waters launches Alliance iS Bio HPLC System to enhance biopharmaceutical QC efficiency. The system reduces errors by up to 40% with MaxPeak HPS Technology, simplifies analyses, and ensures compliance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.77%
Tags
none
Rhea-AI Summary
Waters Corporation (WAT) introduces new Oasis WAX/GCB and GCB/WAX Cartridges to simplify PFAS analysis, reducing sample prep time by 20% and processing time by 30 minutes per batch. The cartridges are QC-tested for low residual PFAS, enhancing accuracy and efficiency in testing. These products aim to meet EPA Method 1633 requirements for various sample types.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.32%
Tags
none
-
Rhea-AI Summary
Waters Corporation (WAT) introduces a new Rheo-Impedance Spectroscopy (Rheo-IS) accessory for its TA Instruments Discovery Hybrid Rheometers, enabling battery scientists to assess electrode slurry composition quality under real-world conditions. The accessory offers friction-free design, full range of rheological and electrical measurements, and easy-to-use software integration.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.44%
Tags
none
-
Rhea-AI Summary
Waters Corporation introduces HPLC CONNECT software, facilitating seamless connectivity between liquid chromatography systems and multi-angle light-scattering instruments for improved efficiency and data confidence in characterizing large molecules. The software simplifies the precise characterization of complex molecules essential for developing biologic drugs, including antibody drug conjugates, other protein conjugates, and gene therapies. Waters aims to enhance ease-of-use and accuracy in SEC-MALS analyses for critical biopharmaceutical innovations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.27%
Tags
none
Rhea-AI Summary
Waters Corporation (WAT) CEO, Udit Batra Ph.D., to participate in fireside chat at TD Cowen 44th Annual Health Care Conference. Live webcast and replay details provided.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.31%
Tags
conferences

FAQ

What is the current stock price of Waters (WAT)?

The current stock price of Waters (WAT) is $408.35 as of January 22, 2025.

What is the market cap of Waters (WAT)?

The market cap of Waters (WAT) is approximately 24.3B.

What industries does Waters Corporation serve?

Waters Corporation serves biopharmaceutical, industrial, and academic/government sectors, providing analytical instruments and software solutions.

What are some of Waters Corporation's recent product launches?

Recent launches include the ACQUITY QDa II Mass Detector, Xevo MRT MS, and Oasis WAX/GCB Cartridges for PFAS analysis.

How does Waters Corporation contribute to scientific advancements?

Waters Corporation pioneers innovations in chromatography, mass spectrometry, and thermal analysis, enabling significant progress in healthcare, environmental management, food safety, and water quality.

What is the significance of the TA Instruments Discovery Hybrid Rheometers?

These rheometers are designed to enable simultaneous electrical impedance and rheological measurements, critical for optimizing battery formulations.

How is Waters Corporation performing financially?

In the first quarter of 2024, Waters Corporation reported sales of $637 million, focusing on innovation and operational efficiency to drive future growth.

Where is Waters Corporation headquartered?

Waters Corporation is headquartered in Milford, Massachusetts, and operates directly in 35 countries.

How many employees does Waters Corporation have?

Waters Corporation employs approximately 8,000 people worldwide.

What are TA Instruments' main products?

TA Instruments specializes in thermal analysis and rheometry solutions, supporting advancements in various scientific fields.

What is the significance of the Oasis WAX/GCB Cartridges?

These cartridges streamline the sample preparation process for PFAS analysis, ensuring accuracy and reducing processing time.

How can I access Waters Corporation's financial results?

Waters Corporation's financial results can be accessed through their Investor Relations website, where live webcasts and replays of financial presentations are available.
Waters Corp

NYSE:WAT

WAT Rankings

WAT Stock Data

24.29B
59.34M
0.05%
96.77%
3.33%
Diagnostics & Research
Laboratory Analytical Instruments
Link
United States of America
MILFORD